93350-01-7 Usage
Description
5-Bromo-4,6-dimethylnicotinic acid is a pyridine derivative and a form of vitamin B3, specifically a brominated variant of 4,6-dimethylnicotinic acid. It is recognized for its potential biological activities, including anti-inflammatory and antioxidant properties, and is widely utilized as an intermediate in the synthesis of pharmaceuticals and other organic compounds. This versatile chemical holds promise for various applications across different industries.
Uses
Used in Pharmaceutical Industry:
5-Bromo-4,6-dimethylnicotinic acid serves as an intermediate in the synthesis of various pharmaceuticals, leveraging its structural properties to contribute to the development of new medications.
Used in Drug Development:
As a compound with demonstrated biological activities, 5-bromo-4,6-dimethylnicotinic acid is utilized in drug development for its potential roles in anti-inflammatory and antioxidant therapies, indicating its use in creating treatments for a range of conditions.
Used in Organic Compounds Synthesis:
5-Bromo-4,6-dimethylnicotinic acid is employed as a key component in the synthesis of other organic compounds, highlighting its importance in the realm of organic chemistry and the creation of novel chemical entities.
Used in Medical Research:
5-BROMO-4,6-DIMETHYLNICOTINIC ACID's biological activities make it a valuable asset in medical research, where it can be explored for its potential to contribute to the understanding and treatment of various diseases and conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 93350-01-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,3,3,5 and 0 respectively; the second part has 2 digits, 0 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 93350-01:
(7*9)+(6*3)+(5*3)+(4*5)+(3*0)+(2*0)+(1*1)=117
117 % 10 = 7
So 93350-01-7 is a valid CAS Registry Number.
93350-01-7Relevant articles and documents
ROR NUCLEAR RECEPTOR MODULATORS
-
, (2016/12/26)
The invention provides compounds of Formula (I) pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers and isomers thereof wherein the variable are defined herein. The compounds of the invention are useful for treating immunological conditions.